SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: out_of_the_loop who wrote (114)1/31/1999 12:33:00 AM
From: Mad2  Read Replies (1) of 5582
 
Howard,
My questions aren't irrelevant. For a company like GUMM to double its market cap from 50-100mil in the span of a few weeks (taking the price to book from a allready high of 10 to 20) I do think its relevant to ask what is behind the companies press releases.

BTW I didn't question if the product existed, I assume it does. Of course when it comes to investing in GUMM a key question is how will the company benifit, which leads to making some assumptions about potential revenues and the piece that GUMM would obtain. Given so little is available, it is appropiate to question the information that has been released.

Every investment decision is speculative. The object is to idenitify those that have upside potential presumably with minimal downside risk. GUMM at a price to book in the high teens poses a lot of downside. It's a great story, but it will take more than a story to maintain share price for more than a few days

Good luck Howard
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext